BD, Fujirebio Partner on Cancer Dx Assays

BD and Fujirebio will develop diagnostic products that contain Fujirebio's biomarkers that will run on BD's multiplex testing platform.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.